7SZQ
Human P300 complexed with an azaindazole inhibitor
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | APS BEAMLINE 22-BM |
| Synchrotron site | APS |
| Beamline | 22-BM |
| Temperature [K] | 93 |
| Detector technology | CCD |
| Collection date | 2019-02-05 |
| Detector | RAYONIX MX300-HS |
| Wavelength(s) | 1 |
| Spacegroup name | P 43 |
| Unit cell lengths | 62.444, 62.444, 103.658 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 44.150 - 2.800 |
| R-factor | 0.1726 |
| Rwork | 0.169 |
| R-free | 0.23480 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 4pzs |
| RMSD bond length | 0.008 |
| RMSD bond angle | 1.033 |
| Data reduction software | HKL-2000 |
| Data scaling software | SCALEPACK |
| Phasing software | MOLREP |
| Refinement software | PHENIX (1.19.2_4158) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 50.000 | 2.850 |
| High resolution limit [Å] | 2.800 | 2.800 |
| Rmerge | 0.063 | 0.835 |
| Number of reflections | 9897 | 510 |
| <I/σ(I)> | 30.2 | 2.29 |
| Completeness [%] | 100.0 | 100 |
| Redundancy | 7.7 | 7.6 |
| CC(1/2) | 1.000 | 0.819 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION | 9.5 | 277 | 30% PEG400, 0.1 M CHES pH 9.5 |






